Merck Moves To Block Generic Ganirelix Fertility Treatment
Whitehouse Station, N.J.-based Merck and subsidiaries Organon USA Inc., MSD Oss BV and Roche Palo Alto LLC allege that Sun and its affiliate Caraco Pharmaceutical Laboratories Inc. infringed two patents covering its highly successful Ganirelix Acetate Injection treatment.
“Upon information and belief, Sun’s submission of ANDA No. 20-4246...
To view the full article, register now.